Patent ID: 11858945
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 6:
7. The compound of claim 1, represented by one of Formulae (XII-1) to (XII-5), or a pharmaceutically acceptable salt thereof:, wherein each R10 is independently selected from:
1) Halogen;
2) —CN;
3) —OR13;
4) —SR13;
5) —NR13R14;
6) —OC(O)NR13R14;
7) Optionally substituted —C1-C6 alkyl;
8) Optionally substituted —C3-C8 cycloalkyl;
9) Optionally substituted 3- to 8-membered heterocycloalkyl;
10) Optionally substituted aryl; and
11) Optionally substituted heteroaryl;

m is 0, 1, 2, 3, or 4; R1, and R3 are as defined in claim 1.